跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,224 条关于
“cALD”
全部
2,224
临床试验
1,898
药物
90
机构
22
资讯
214
去年
EMA Initiates Accelerated Review for Bluebird's Gene Therapy Targeting Rare Disease CALD
上个月
Language Barriers Put CALD Australians at Heightened Risk of Medicine Harm, PSA Report Finds
去年
Leriglitazone Shows Promise in Slowing cALD Progression in Children
去年
Gene Therapy Skysona Linked to Hematological Cancers in CALD Patients
去年
Gene Therapy for CALD Shows Long-Term Efficacy but Carries Hematologic Cancer Risk
去年
Minoryx and Neuraxpharm Submit New Marketing Authorization Application for Leriglitazone in Cerebral Adrenoleukodystrophy
上个月
CHMP Recommends Minoryx's NEZGLYAL as First Pharmacological Treatment for Pediatric Cerebral Adrenoleukodystrophy
去年
FDA Restricts Bluebird Bio's Skysona Gene Therapy Following Tripled Cancer Risk
去年
Bluebird Bio's Skysona Linked to Blood Cancers in Pediatric Patients
去年
CHMP Rejects Neuraxpharm and Apellis Drugs, Companies to Appeal
第 1 页,共 22 页
上一页
下一页